ACM
ISEE

AlphaCrest Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

AlphaCrest Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-52,506
Closed -$505K – 1422
2022
Q2 		$505K Buy
52,506
+25,813
+97% +$324K 0.02% 953
2022
Q1 		$449K Buy
+26,693
New +$395K 0.03% 944

Other funds holding ISEE

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

AlphaCrest Capital Management's ISEE Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2022, closing a stake of 52,506 shares — an estimated $505K sold.

AlphaCrest Capital Management first reported a position in ISEE in Q1 2022 and held it in 2 quarters. The position peaked at $505K in Q2 2022. 213 funds tracked by Wall St. Rank hold ISEE as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 52,506 IVERIC bio, Inc. Common Stock shares in Q3 2022, an estimated $505K.
  • AlphaCrest Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • AlphaCrest Capital Management's IVERIC bio, Inc. Common Stock position peaked at $505K in Q2 2022.
  • 213 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.